Last reviewed · How we verify

NCT06621264: EXACT-CKDPAD

Exercise Activity to Improve Mobility in Patients With CKD and PAD

Recruiting now NA Last updated 31 May 2025
What this trial tests

NA trial testing EXERCISE TRAINING WITH OR WITHOUT MEDICATION in Chronic Kidney Disease Stage 3 and 4 in 124 participants. Currently enrolling.

Timeline
1 October 2024
Primary endpoint
20 November 2025
31 December 2026

Quick facts

Lead sponsorUniversity Hospital of Ferrara
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment124
Start date1 October 2024
Primary completion20 November 2025
Estimated completion31 December 2026
Sites3 locations across Italy

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital of Ferrara

Who can join

Adults 18 to 80, any sex, with Chronic Kidney Disease Stage 3 and 4 or Peripheral Artery Disease (PAD). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

People affected by chronic kidney disease and concomitant diagnosed peripheral artery disease at intermediate stages, without contraindications to exercise therapy will be invited to participate in the study. Whose providing informed consent, will be randomly assigned to one of two groups: 1. Exercise program receiving two daily 10-minute interval walking sessions at a slow increasing speed. 2. Control group: receiving usual care including optimal medical therapy and nutritional advice. Patients of both groups will be measured at baseline, after the end of the exercise program (6-month) and at follow up (12-month). Outcome measures will include walking ability by the 6-minute walking test (primary outcome) and lower limbs perfusion, body composition, quality of life, laboratory outcomes and long-term hospitalizations.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Clinical management of peripheral arterial disease in chronic kidney disease-a comprehensive review from the European Renal Association CKD-MBD Working Group.
    Huish S, Nawaz S, Bellasi A, Diaz-Tocados JM, et al · · 2025 · cited 4× · PMID 40599821 · DOI 10.1093/ckj/sfaf089
  2. Exercise therapy to improve mobility, active behaviour and quality of life of chronic kidney disease patients with peripheral artery disease: study protocol for the EXACT-CKDPAD multicentre randomised controlled trial.
    Manfredini F, Panuccio V, Battaglia Y, Storari A, et al · · 2025 · PMID 40672525 · DOI 10.1136/bmjsem-2025-002740

Verify or expand the search:

Other trials of EXERCISE TRAINING WITH OR WITHOUT MEDICATION

Trials testing the same drug.

Other recruiting trials for Chronic Kidney Disease Stage 3 and 4

Currently open trials in the same condition.

Other University Hospital of Ferrara trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06621264.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing